Hohenleitner Susan 4

What Happened

• Susan Hohenleitner, Chief Financial Officer of Ardelyx, received equity awards on January 23, 2026: 85,670 restricted stock units (RSUs) and 128,505 derivative awards/options. Both awards were reported with an acquisition price of $0.00 (no cash paid). The filing was submitted to the SEC on January 26, 2026. These awards are grants (not open‑market purchases or sales).

Key Details

• Transaction date: 2026-01-23; SEC filing date: 2026-01-26.
• Award amounts and prices: 85,670 RSUs @ $0.00; 128,505 derivative award units/options @ $0.00.
• Shares owned following the reported transaction: not disclosed in the Form 4 summary provided.
• Footnote F1: RSUs — each RSU converts to one share of common stock upon vesting.
• Footnote F2: The derivative award/option vests in 48 equal monthly installments beginning January 23, 2026; the option becomes exercisable as it vests (subject to continued employment).
• No immediate sale or exercise reported; this is an equity grant/compensation event, not a market purchase or sale.

Context

• RSU grants and time‑vesting options are common executive compensation tools to align management incentives with shareholders; they do not involve cash outlay by the insider at grant and only result in shares when/if vested (and exercised, if applicable).
• Because these are awards (not purchases or sales), they do not directly signal the insider buying or selling stock in the open market.